Krystal Biotech, Inc.
News
Krystal Biotech (NASDAQ:KRYS) Given New $220.00 Price Target at Stifel Nicolaus
Ticker Report Krystal Biotech (NASDAQ:KRYS - Free Report) had its target price boosted by Stifel Nicolaus from $204.00 to $220.00 in a report published on Wednesday morning, Benzinga reports. They currently have a...\n more…
Victory Capital Management Inc. Buys 9,045 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)
Ticker Report Victory Capital Management Inc. boosted its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 6.7% in the second quarter, according to its most recent 13F filing with the...\n more…
TD Asset Management Inc Sells 11,082 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)
Ticker Report TD Asset Management Inc lowered its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 16.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities...\n more…
Krystal Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference
Globe Newswire PITTSBURGH, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the Company ) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in...\n more…
Zurcher Kantonalbank Zurich Cantonalbank Has $819,000 Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS)
Zolmax Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Krystal Biotech, Inc. (NASDAQ:KRYS - Free Report) by 3.9% in the 2nd quarter, according to the company in its most recent filing with...\n more…